KLI

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer

Metadata Downloads
Publisher
BRITISH JOURNAL OF CANCER
Language
영어
ISSN
0007-0920
Citation Volume
124
Citation Number
2
Citation Start Page
383
Citation End Page
390
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.